Hygiena 2016, 61(4):172-175

Lung Cancer and HPV Infections

Petr Ambroz, Jana Janoutová, Vladimír Janout
Ostravská univerzita, Lékařská fakulta, Ústav epidemiologie a ochrany veřejného zdraví, Ostrava, Česká republika

Summary information is presented regarding latest knowledge on human papillomavirus and its role as a risk factor for lung cancer. Results of studies are inconsistent and IARC has not issued any declaration on the classification of HPV as a human carcinogen playing any role in the etiology of lung cancer.

Keywords: human papilomavirus (HPV), lung cancer, risk factors

Received: March 2016; Accepted: October 11, 2016; Published: December 1, 2016  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Ambroz P, Janoutová J, Janout V. Lung Cancer and HPV Infections. Hygiena. 2016;61(4):172-175.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Driák D, Sehnal B. Význam infekcí způsobených lidskými papilomaviry. Čas Lék Čes. 2013;152 (1):15-9. (In Czech.)
    2. Travis WD, Brambilla E, Riely GJ. New pathologic classification of lung cancer: relevance for clinical practice and clinical trials. J Clin Oncol. 2013;31(8):992-1001. Go to original source... Go to PubMed...
    3. Dundr P, Hornychová H, Matěj R, Ryška A, Staněk L, Tichý T. Doporučený postup pro histologické vyšetření karcinomu plic [Internet]. Praha: Společnost českých patologů ČLS JEP; 2013 [cited 2016 Mar 1]. Dostupné z: http://docplayer.cz/345573-Doporuceny-postup-pro-histologicke-vysetreni-karcinomu-plic.html. (In Czech.)
    4. de Villiers EM, Fauquet C, Broker TR, Bernard HU, zur Hausen H, Classification of papillomaviruses. Virology. 2004;324(1):17-27. Go to original source... Go to PubMed...
    5. Tan TM, Ting RC. In vitro and in vivo inhibition of human papillomavirus type 16 E6 and E7 genes. Cancer Res. 1995;55:4599-605.
    6. Mechl Z. Lovasová Z. Lidský papilomavirus a nádory hlavy a krku. Remedia. 2010;20(1):81-5. (In Czech.)
    7. Zandberg DP, Bhargava R, Badin S, Cullen KJ. The role of human papillomavirus in nongenital cancers. CA Cancer J Clin. 2013;63(1):57-81. Go to original source... Go to PubMed...
    8. WHO/IARC. IARC Monographs on the evaluation of carcinogenic risks to humans [Internet]. Lyon: IARC; 2016 [cited 2016 Oct 11]. Available from: http://monographs.iarc.fr/ENG/Classification.
    9. Syrjänen K, Syrjänen S, Kellokoski J, Kärjä J, Mäntyjärvi R. Human papillomavirus (HPV) type 6 and 16 DNA sequences in bronchial squamous cell carcinom as demonstrated by in situ DNA hybridization. Lung. 1989;167(1):33-42. Go to original source... Go to PubMed...
    10. Soini Y, Nuorva K, Kamel D, Pöllänen R, Vähäkangas K, Lehto VP, et al. Presence of human papillomavirus DNA and abnormal p53 protein accumulation in lung carcinoma, Thorax. 1996;51(9):887-93. Go to original source... Go to PubMed...
    11. Cheng YW, Wu MF, Wang J, Yeh KT, Goan YG, Chiou HL. Human papillomavirus 16/18 E6 oncoprotein is expressed in lung cancer and related with p53 inactivation. Cancer Res. 2007;67(22):10686-93. Go to original source... Go to PubMed...
    12. Syrjänen KJ. HPV infections and lung cancer. J Clin Pathol. 2002;55(12):885-91. Go to original source...
    13. Srinivasan M, Taioli E, Ragin CC. Human papillomavirus type 16 and 18 in primary lung cancers-a meta-analysis. Carcinogenesis. 2009;30(10):1722-8. Go to original source... Go to PubMed...
    14. Syrjänen K. Detection of human papillomavirus in lung cancer: systematic review and meta-analysis. Anticancer Res. 2012;32(8):3235-50.
    15. Ragin C, Obikoya-Malomo M, Kim S, Chen Z, Flores-Obando R, Gibbs D, et al. HPV-associated lung cancers: an international pooled analysis. Carcinogenesis. 2014;35(6):1268-75. Go to original source... Go to PubMed...
    16. Zhai K, Ding J, Shi HZ. HPV and lung cancer risk: a meta-analysis. J Clin Virol. 2015;63:84-90. Go to original source... Go to PubMed...
    17. Vanner EA, Shroyer KR. Comments on "HPV and lung cancer risk: a meta-analysis" [Zhai et al., J. Clin. Virol. (in press)]. J Clin Virol. 2015;63:91. Go to original source... Go to PubMed...
    18. Hsu NY, Lee H, Yen Y, Cheng YW. Human papillomavirus and non-small cell lung cancer. Thorac Cancer. 2013;4(4):345-53. Go to original source... Go to PubMed...
    19. Cheng YW, Chiou HL, Sheu GT, Hsieh LL, Chen JT, Chen CY, et al. The association of human papillomavirus 16/18 infection with lung cancer among nonsmoking Taiwanese women. Cancer Res. 2001;61(7):2799-803.
    20. Hasegawa Y, Ando M, Kubo A, Isa S, Yamamoto S, Tsujino K, et al. Human papilloma virus in non-small cell lung cancer in never smokers: a systematic review of the literature. Lung Cancer. 2014;83(1):8-13. Go to original source... Go to PubMed...
    21. Simen-Kapeu A, Surcel HM, Koskela P, Pukkala E, Lehtinen M. Lack of association between human papillomavirus type 16 and 18 infections and female lung cancer. Cancer Epidemiol Biomarkers Prev. 2010;19(7):1879-81. Go to original source... Go to PubMed...
    22. Park MS, Chang YS, Shin JH, Kim DJ, Chung KY, Shin DH, et al. The prevalence of human papillomavirus infection in Korean non-small cell lung cancer patients. Yonsei Med J. 2007; 48(1):69-77. Go to original source... Go to PubMed...
    23. Anantharaman D, Gheit T, Waterboer T, Halec G, Carreira C, Abedi-Ardekani B, et al. No causal association identified for human papillomavirus infection in lung cancer. Cancer Res. 2014;74(13):3525-34. Go to original source... Go to PubMed...

    Return to the content